Literature DB >> 23062225

Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients.

Joaquim Bellmunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062225     DOI: 10.1016/j.eururo.2012.09.062

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments.

Authors:  Tian Yi Zhang; Neeraj Agarwal; Guru Sonpavde; Giuseppe DiLorenzo; Joaquim Bellmunt; Nicholas J Vogelzang
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 2.862

Review 2.  Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer.

Authors:  Heather Cox; Megan Hames; Mona Benrashid
Journal:  J Adv Pract Oncol       Date:  2015-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.